These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 32400968)

  • 1. Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy.
    Miao P; Tang S; Ye J; Wang J; Lou Y; Zhang B; Xu X; Chen X; Li Y; Feng J
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1250. PubMed ID: 32400968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
    Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
    Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.
    Begemann A; Acuña MA; Zweier M; Vincent M; Steindl K; Bachmann-Gagescu R; Hackenberg A; Abela L; Plecko B; Kroell-Seger J; Baumer A; Yamakawa K; Inoue Y; Asadollahi R; Sticht H; Zeilhofer HU; Rauch A
    Mol Med; 2019 Feb; 25(1):6. PubMed ID: 30813884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of
    Berecki G; Howell KB; Deerasooriya YH; Cilio MR; Oliva MK; Kaplan D; Scheffer IE; Berkovic SF; Petrou S
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5516-E5525. PubMed ID: 29844171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders.
    Berg AT; Thompson CH; Myers LS; Anderson E; Evans L; Kaiser AJE; Paltell K; Nili AN; DeKeyser JL; Abramova TV; Nesbitt G; Egan SM; Vanoye CG; George AL
    Brain; 2024 Aug; 147(8):2761-2774. PubMed ID: 38651838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of electrophysiological dysfunction and clinical severity in SCN2A-related epilepsies.
    Lauxmann S; Verbeek NE; Liu Y; Zaichuk M; Müller S; Lemke JR; van Kempen MJA; Lerche H; Hedrich UBS
    Hum Mutat; 2018 Dec; 39(12):1942-1956. PubMed ID: 30144217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive In Vitro Phenotypes in iPSC-Derived Neurons From Patients With Gain- and Loss-of-Function
    Mao M; Mattei C; Rollo B; Byars S; Cuddy C; Berecki G; Heighway J; Pachernegg S; Menheniott T; Apted D; Jia L; Dalby K; Nemiroff A; Mullen S; Reid CA; Maljevic S; Petrou S
    J Neurosci; 2024 Feb; 44(8):. PubMed ID: 38148154
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
    Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
    Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotype study of SCN2A gene related epilepsy].
    Zeng Q; Zhang YH; Yang XL; Zhang J; Liu AJ; Liu XY; Jiang YW; Wu XR
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):518-523. PubMed ID: 29996185
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Yang XR; Ginjupalli VKM; Theriault O; Poulin H; Appendino JP; Au PYB; Chahine M
    J Neurophysiol; 2022 May; 127(5):1388-1397. PubMed ID: 35417276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and pharmacological evaluation of a novel SCN2A variant linked to early-onset epilepsy.
    Adney SK; Millichap JJ; DeKeyser JM; Abramova T; Thompson CH; George AL
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1488-1501. PubMed ID: 32750235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Functional Changes of Nav1.2 Channel Causing
    Miao P; Tang S; Ye J; Tang J; Wang J; Zheng C; Li Y; Feng J
    Front Neurol; 2021; 12():653517. PubMed ID: 34093402
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced slow inactivation contributes to dysfunction of a recurrent SCN2A mutation associated with developmental and epileptic encephalopathy.
    Ganguly S; Thompson CH; George AL
    J Physiol; 2021 Sep; 599(18):4375-4388. PubMed ID: 34287911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy.
    Dilena R; Striano P; Gennaro E; Bassi L; Olivotto S; Tadini L; Mosca F; Barbieri S; Zara F; Fumagalli M
    Brain Dev; 2017 Apr; 39(4):345-348. PubMed ID: 27876397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence.
    Melikishvili G; Dulac O; Gataullina S
    Epilepsy Behav; 2020 Oct; 111():107187. PubMed ID: 32603808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nav1.2 channel mutations preventing fast inactivation lead to SCN2A encephalopathy.
    Berecki G; Tao E; Howell KB; Coorg RK; Andersen E; Kahlig K; Wolff M; Corry B; Petrou S
    Brain; 2024 Jun; ():. PubMed ID: 38939966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.
    Wolff M; Brunklaus A; Zuberi SM
    Epilepsia; 2019 Dec; 60 Suppl 3():S59-S67. PubMed ID: 31904126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features.
    Liang JS; Lin LJ; Yang MT; Wang JS; Lu JF
    Brain Dev; 2017 Nov; 39(10):877-881. PubMed ID: 28709814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CaMKII modulates sodium current in neurons from epileptic
    Thompson CH; Hawkins NA; Kearney JA; George AL
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1696-1701. PubMed ID: 28137877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.